Latest advances in brain tumor immunotherapy
- Submission status
- Open
- Submission deadline
This cross-journal Collection aims to highlight the latest advances in research for brain tumor immunology and immunotherapy. The goal of the Collection will be to bridge our understanding of basic, translational, and clinical immune-based research in the context of brain tumors, as well as offer expert commentary on emerging strategies and next-generation efforts toward harnessing the power of the immune system to treat tumors in the brain.
This is a joint collaboration between npj Precision Oncology, npj Vaccines and Scientific Reports. Authors should refer to the aims and scope of each participating journal to determine the most appropriate journal for their manuscript. Submissions are welcome on a rolling basis.
Editors
-
Bryan Choi, MD, PhD
Massachusetts General Hospital and Harvard Medical School, USA.
-
Lukas Bunse, MD, PhD
German Cancer Research Center, Heidelberg, Germany
This Collection is open for submissions from all authors – and not by invitation only – on the condition that the manuscripts fall within the scope of the Collection and of npj Precision Oncology, npj Vaccines or Scientific Reports more generally.
All manuscripts will be considered for publication according to the editorial policies of the specific journal through which they are submitted, namely npj Precision Oncology, npj Vaccines or Scientific Reports. Visit Nature portfolio’s Collections guidelines for more details.
When submitting your manuscript to npj Precision Oncology, npj Vaccines or Scientific Reports via our online submission system, please choose the appropriate Collection title from the drop-down menu on the submission form. Please be sure to express your interest in the Collection in your cover letter. Please only submit to one journal, but note authors have the option to transfer to another participating journal following the editors’ recommendation.
This Collection has not been supported by sponsorship.
